Penumbra (PEN) Other Operating Expenses (2018 - 2024)

Penumbra (PEN) posted quarterly Other Operating Expenses of $76.9 million for Q2 2024, up 322.43% quarter-over-quarter from $18.2 million in Q3 2023.

Penumbra (PEN) Other Operating Expenses (2018 - 2024) Analysis & Trends

Penumbra (PEN) has reported Other Operating Expenses for 3 consecutive years, with $76.9 million the latest figure, recorded in Q2 2024.

In Q2 2024, Other Operating Expenses changed N/A year-over-year to $76.9 million; the TTM figure through Mar 2025 stood at $76.9 million (up 322.43% YoY), while the FY2024 annual figure was $76.9 million, up 322.43% from the prior year.
Other Operating Expenses advanced to $76.9 million in Q2 2024 per PEN's latest filing, from $18.2 million in the prior quarter.
Across five years, Other Operating Expenses topped out at $76.9 million in Q2 2024 and bottomed at $18.2 million in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	200.20 Bn	194.60 Bn	7.27 Bn
2	Stryker	129.69 Bn	126.21 Bn	4.50 Bn
3	Medtronic	120.14 Bn	110.92 Bn	6.41 Bn
4	Boston Scientific	74.16 Bn	73.62 Bn	3.85 Bn
5	Edwards Lifesciences	52.68 Bn	48.43 Bn	1.35 Bn
6	Dexcom	34.57 Bn	32.62 Bn	830.00 Mn
7	GE HealthCare Technologies	34.09 Bn	31.98 Bn	2.18 Bn
8	Koninklijke Philips	26.49 Bn	23.17 Bn	4.55 Bn
9	Steris	23.19 Bn	22.70 Bn	684.20 Mn
10	Penumbra	12.81 Bn	12.15 Bn	264.94 Mn

Download Data